194 related articles for article (PubMed ID: 28237731)
1. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
Vieites M; Otero L; Santos D; Olea-Azar C; Norambuena E; Aguirre G; Cerecetto H; González M; Kemmerling U; Morello A; Diego Maya J; Gambino D
J Inorg Biochem; 2009 Mar; 103(3):411-8. PubMed ID: 19187969
[TBL] [Abstract][Full Text] [Related]
3. Effect of Fluorination on the Structure and Anti-
Salsi F; Bulhões Portapilla G; Simon S; Roca Jungfer M; Hagenbach A; de Albuquerque S; Abram U
Inorg Chem; 2019 Aug; 58(15):10129-10138. PubMed ID: 31310108
[TBL] [Abstract][Full Text] [Related]
4. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
[TBL] [Abstract][Full Text] [Related]
5. Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.
Pagano M; Demoro B; Toloza J; Boiani L; González M; Cerecetto H; Olea-Azar C; Norambuena E; Gambino D; Otero L
Eur J Med Chem; 2009 Dec; 44(12):4937-43. PubMed ID: 19783078
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.
Demoro B; Rossi M; Caruso F; Liebowitz D; Olea-Azar C; Kemmerling U; Maya JD; Guiset H; Moreno V; Pizzo C; Mahler G; Otero L; Gambino D
Biol Trace Elem Res; 2013 Jun; 153(1-3):371-81. PubMed ID: 23564472
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
Vieites M; Otero L; Santos D; Toloza J; Figueroa R; Norambuena E; Olea-Azar C; Aguirre G; Cerecetto H; González M; Morello A; Maya JD; Garat B; Gambino D
J Inorg Biochem; 2008; 102(5-6):1033-43. PubMed ID: 18226837
[TBL] [Abstract][Full Text] [Related]
8. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.
Fernández M; Arce ER; Sarniguet C; Morais TS; Tomaz AI; Azar CO; Figueroa R; Diego Maya J; Medeiros A; Comini M; Helena Garcia M; Otero L; Gambino D
J Inorg Biochem; 2015 Dec; 153():306-314. PubMed ID: 26275470
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
10. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
11. Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones.
Otero L; Maya JD; Morello A; Rigol C; Barriga G; Rodríguez J; Folch C; Norambuena E; González M; Azar CO; Cerecetto H; Gambino D
Med Chem; 2008 Jan; 4(1):11-7. PubMed ID: 18220967
[TBL] [Abstract][Full Text] [Related]
12. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.
Otero L; Vieites M; Boiani L; Denicola A; Rigol C; Opazo L; Olea-Azar C; Maya JD; Morello A; Krauth-Siegel RL; Piro OE; Castellano E; González M; Gambino D; Cerecetto H
J Med Chem; 2006 Jun; 49(11):3322-31. PubMed ID: 16722651
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
Aguirre G; Boiani L; Cerecetto H; Fernández M; González M; Denicola A; Otero L; Gambino D; Rigol C; Olea-Azar C; Faundez M
Bioorg Med Chem; 2004 Sep; 12(18):4885-93. PubMed ID: 15336268
[TBL] [Abstract][Full Text] [Related]
14. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
15. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
[TBL] [Abstract][Full Text] [Related]
16. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
[TBL] [Abstract][Full Text] [Related]
17. Development of new dinuclear Fe(III) coordination compounds with
Moreira FF; Portes JA; Barros Azeredo NF; Fernandes C; Horn A; Santiago CP; Segat BB; Caramori GF; Madureira LMP; Candela DRS; Marques MM; Lamounier Camargos Resende JA; de Souza W; DaMatta RA; Seabra SH
Dalton Trans; 2021 Sep; 50(35):12242-12264. PubMed ID: 34519725
[TBL] [Abstract][Full Text] [Related]
18. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
19. The characterization of anti-T. cruzi activity relationships between ferrocenyl, cyrhetrenyl complexes and ROS release.
Echeverría C; Romero V; Arancibia R; Klahn H; Montorfano I; Armisen R; Borgna V; Simon F; Ramirez-Tagle R
Biometals; 2016 Aug; 29(4):743-9. PubMed ID: 27460450
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
